NVO vs. SMSN.L
NVO (Novo Nordisk A/S) and SMSN.L (Samsung Electronics Co. Ltd) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while SMSN.L operates in Consumer Electronics (Technology). Over the past 10 years, NVO returned 7.56%/yr vs 27.99%/yr for SMSN.L. At a 0.11 correlation, their price movements are largely independent.
Performance
NVO vs. SMSN.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a -10.74% return, which is significantly lower than SMSN.L's 161.93% return. Over the past 10 years, NVO has underperformed SMSN.L with an annualized return of 7.56%, while SMSN.L has yielded a comparatively higher 27.99% annualized return.
NVO
- 1D
- -0.18%
- 1M
- -6.80%
- YTD
- -10.74%
- 6M
- -9.50%
- 1Y
- -43.34%
- 3Y*
- -15.59%
- 5Y*
- 2.92%
- 10Y*
- 7.56%
SMSN.L
- 1D
- 6.51%
- 1M
- 13.49%
- YTD
- 161.93%
- 6M
- 204.19%
- 1Y
- 399.27%
- 3Y*
- 59.18%
- 5Y*
- 26.81%
- 10Y*
- 27.99%
NVO vs. SMSN.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | -10.74% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
SMSN.L Samsung Electronics Co. Ltd | 161.93% | 130.81% | -37.94% | 38.34% | -31.32% | -8.01% | 60.01% | 41.56% | -25.35% | 62.93% |
Correlation
The correlation between NVO and SMSN.L is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Aug 24, 2006 | 0.11 |
Fundamentals
NVO:
$195.21B
SMSN.L:
$1.46T
NVO:
DKK 27.42
SMSN.L:
₩320.04K
NVO:
10.34
SMSN.L:
25.63
NVO:
0.44
SMSN.L:
0.77
NVO:
3.85
SMSN.L:
5.67
NVO:
6.21
SMSN.L:
4.68
NVO:
DKK 327.80B
SMSN.L:
₩389.99T
NVO:
DKK 268.30B
SMSN.L:
₩152.35T
NVO:
DKK 181.54B
SMSN.L:
₩68.67T
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. SMSN.L — Risk / Return Rank
NVO
SMSN.L
NVO vs. SMSN.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Samsung Electronics Co. Ltd (SMSN.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | SMSN.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -8.60 | ||
| Sortino ratioReturn per unit of downside risk | -6.84 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.75 | -0.90 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | 18.03 | -18.83 |
| Martin ratioReturn relative to average drawdown | -1.18 | 57.94 | -59.12 |
Loading charts...
Drawdowns
NVO vs. SMSN.L - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, which is greater than SMSN.L's maximum drawdown of -55.59%. Use the drawdown chart below to compare losses from any high point for NVO and SMSN.L.
Loading charts...
Drawdown Indicators
| NVO | SMSN.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -55.59% | -19.11% |
Max Drawdown (1Y)Largest decline over 1 year | -54.34% | -21.96% | -32.38% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -44.52% | -30.18% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -49.12% | -25.58% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | -54.44% | -20.26% |
Current DrawdownCurrent decline from peak | -68.11% | -8.55% | -59.56% |
Average DrawdownAverage peak-to-trough decline | -17.79% | -17.37% | -0.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.62% | 6.85% | +30.77% |
Volatility
NVO vs. SMSN.L - Volatility Comparison
The current volatility for Novo Nordisk A/S (NVO) is 10.68%, while Samsung Electronics Co. Ltd (SMSN.L) has a volatility of 20.71%. This indicates that NVO experiences smaller price fluctuations and is considered to be less risky than SMSN.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | SMSN.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.68% | 20.71% | -10.03% |
Volatility (6M)Calculated over the trailing 6-month period | 38.04% | 43.80% | -5.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.88% | 51.06% | +0.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.33% | 34.83% | +3.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.56% | 32.95% | -0.39% |
Dividends
NVO vs. SMSN.L - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 4.11%, more than SMSN.L's 0.35% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 4.11% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
SMSN.L Samsung Electronics Co. Ltd | 0.35% | 0.94% | 2.88% | 1.79% | 2.50% | 1.85% | 3.60% | 2.47% | 3.65% | 1.62% | 1.68% | 1.71% |
Financials
NVO vs. SMSN.L - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Samsung Electronics Co. Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVO vs. SMSN.L - Profitability Comparison
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
SMSN.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Samsung Electronics Co. Ltd reported a gross profit of 81.91T and revenue of 133.87T. Therefore, the gross margin over that period was 61.2%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
SMSN.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Samsung Electronics Co. Ltd reported an operating income of 58.98T and revenue of 133.87T, resulting in an operating margin of 44.1%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
SMSN.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Samsung Electronics Co. Ltd reported a net income of 48.66T and revenue of 133.87T, resulting in a net margin of 36.4%.
Frequently Asked Questions
NVO and SMSN.L have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NVO and SMSN.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer